Master Alliance Provisions Guide (MAPGuide)

MPP – Afrigen Biologics, COVID-19 mRNA-Based Vaccines and Therapeutics, Grant Agreement

  • Intellectual Property | Ownership of IP

8. Intellectual Property

8.1 Background Rights. Except as expressly provided in Section 8.3, neither MPP nor Afrigen transfers by operation of this Agreement or otherwise any intellectual or tangible property right, including patent right, copyright, or any other proprietary right owned as of the commencement date of this Agreement or arising outside of the Project. Nothing to the contrary shall be implied and all such rights, titles and interests are reserved.

8.2 Inventions.Inventions” means all ideas, inventions or discoveries conceived, first created or made in the performance the Project, and if solely by MPP shall be owned by MPP, solely by Afrigen shall be owned by Afrigen, or jointly by Afrigen and MPP shall be jointly owned by the Parties. In case of joint ownership, both MPP and Afrigen shall ask for the other Party’s prior written consent for the exercise of such joint ownership including, without limitation any disposal, protection, sale, management or security over such rights. Afrigen will provide MPP with a disclosure of all the data generated under this Agreement and each Invention in such detail as MPP may reasonably require in the reports provided in accordance with Section 6.1.